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Abstract
Degeneration of the rod and cone photoreceptors in the human retina is among the most common
causes of blindness. Replacing these damaged photoreceptors may help to restore vision.
Repairing the damaged retina relies on the insertion of new, healthy cells. Embryonic stem (ES)
cells and induced pluripotent stem (iPS) cells are two possible sources of photoreceptors to
restore vision. Previous data shows that human ES cells and iPS cells can be differentiated into
photoreceptors and transplanted into the eye to restore some vision. However, this process is
inefficient, and costly. Here, we show a new method for inducing photoreceptor production from
undifferentiated cells through the use of small molecules. Additionally, we aim to mimic retinal
degenerations through oxidative stress to examine diseases such as diabetic retinopathy.
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Background
Retina Structure and Diseases
The vertebrate retina is composed of multiple cells types, including rod and cone
photoreceptors, the retinal pigmented epithelium, ganglion and amacrine cells. These cells
organize into layers to form the neural retina (Figure 1). Degenerations of the rod and cone
photoreceptors in the human retina are a major cause of blindness and affect millions of people
in the United States. Age-related macular degeneration (AMD) and retinitis pigmentosa (RP) are
two of the leading causes of blindness in adults. Both diseases involve the loss of the light
sensitive rod and cone cells that line the retina, causing decreased sensitivity to light, and the
progressive loss of vision. One of the main issues regarding blindness is that most people do not
notice any vision impairment until roughly 90% of their photoreceptors have degenerated. There
are currently no treatments to halt or delay the onset and progression of these diseases. However,
the replacement of photoreceptors through transplantation into the retina has been shown to
restore light sensitivity in mice (Lamba et al., 2009), and represents a possible form of treatment.
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Figure 1: Anatomy of the eye displays the relative relationship between the photoreceptors and
the Retinal Pigment Epithelium (RPE). Light passes through the Ganglion Cell Layer (GCL),
Inner Nuclear Layer (INL), and Outer Nuclear Layer (ONL) before detected by the rod and cone
photoreceptors. (Figure courtesy of Dr. Deepak Lamba)

Pluripotent Stem Cells and Disease Progression
Human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells offer a
therapeutic approach to treating diseases of the retina. Human embryonic stem cells are
undifferentiated cells that are collected from the inner cell mass of human embryos. These cells
can be differentiated into any of the three germ layers, and are capable of virtually limitless selfrenewal. However, given the nature of the method in which they are collected, there are ethical
concerns surrounding the use of hES cells. In order to circumvent this issue, human induced iPS
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cells were generated. These cells are derived from adult somatic cells, commonly lymphocytes or
fibroblasts, and avoid any need for embryonic cells. Once the somatic cells are collected, they
are transformed into undifferentiated cells, which are then capable of being differentiated similar
to hES cells.
The generation of iPS cells allows for different cell lines to be redirected into
undifferentiated cells, and then differentiated into various cell types (Takahashi and Yamanaka,
2006). Several groups have shown that these iPS cells can be used to study specific diseases
(Dimos et al., 2008). By taking a lymphocyte from a patient with a disease of interest, and a
person without the disease, undifferentiated iPS cells can be grown from each, and differentiated
into the cell type impacted by the disease. This can be useful to study disease progression, and to
compare the gene expression levels photoreceptors derived from the two individuals over time,
to gain an understanding of the underlying cause of the disease. This technique can be useful to
study the development and maturation of photoreceptors derived from patients with either AMD
of RP.
One possible treatment for retinal degenerative disorders is cell replacement therapy.
Differentiation of either hES cells and iPS cells into retinal progenitors allows these cells to be
expanded and matured to become photoreceptors, (Lamba et al., 2009). Previous studies have
shown that mice and human photoreceptors can integrate into the retina of adult mice and even
restore function (Lamba et al., 2009; MacLaren et al., 2006). However, the rate of successful
integration of these cells is relatively low. Additionally, the transplanted photoreceptors are
susceptible to the same degenerations as the native cells. This issue places great importance of
higher rates of integration, as well as creating mature and functional photoreceptors en masse for
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sequential transplantations. Stem cells provide a self-renewing source of cells that can be
differentiated on a large enough scale to provide this method of cell replacement.
Creating photoreceptors from pluripotent stem cells requires a specific protocol in order
to properly induce retinal differentiation. Proper forebrain development of the nervous system
relies on two critical signaling pathways: the BMP and Wnt pathways (Niehrs, 2001). More
specifically, induction of retinal cells through recombinant proteins can be achieved by creating
low levels of BMP and Wnt signaling (del Barco Barrantes et al., 2003). Dickkopf-1 (Dkk1) and
Noggin have been shown to inhibit Wnt and BMP signaling, respectively. Although the precise
mechanism of these genes is currently unknown, inhibition of Dkk1 and Noggin in mice
embryos leads to a lack of eyes and other abnormalities in head development. In addition,
Insulin-like growth factor 1 (IGF1) has been shown to promote eye induction (Pera et al., 2001).
Wnt signaling is associated with development of the spinal cord, midbrain and hindbrain
(Castelo-Branco et al., 2003; McMahon and Bradley, 1990). In contrast, inhibition of Wnt
activity during this period of embryonic development is associated with forebrain induction
(Mukhopadhyay et al., 2001; Sanges et al., 2013). Several studies have shown that the inhibition
of the BMP pathway in the embryo pushes developing cells towards a neural fate (HemmatiBrivanlou et al., 1994; Lamb et al., 1993; Smith et al., 1993).
Inhibition of these pathways requires recombinant proteins. However, recombinant
proteins are relatively expensive and slow acting in vitro. The use of small molecule inhibitors of
these pathways at precise stages helps to push for specific differentiation (Nelson et al., 2007)
and would allow more precise control of the cell types formed during differentiation. The
progression of retinal and photoreceptor differentiation can be tracked looking at expression
levels of several different genes including eye field transcription factors (EFTFs) such as Pax6,
4

Six2, Lhx2 and Rx as well as photoreceptor specific genes such as Crx, Blimp1, and Recoverin.
These genes are upregulated during the early stages of differentiation and can be used to
investigate whether the stem cells are taking on the desired cell fate (Lamba et al., 2006).
One possible treatment for diseases such as AMD and retinitis pigmentosa relies on
transplantation of new photoreceptors into the retina. Efficient production of healthy and mature
photoreceptors is crucial for the advancement of regenerative therapies for the treatment of AMD
and retinitis pigmentosa. Creating these photoreceptors from hES cells and iPS cells through
current protocols is time-consuming and labor-intensive. In addition, the recombinant proteins
used are expensive and degrade quickly. Replacing these recombinant proteins with small
molecule analogs may increase the overall percentage of pluripotent cells that differentiate into
photoreceptors in a faster, more cost effective manner (Osakada et al., 2009). The current
methods for transplanting photoreceptors into mouse eyes result in a low success rate of
integrated cells. The two approaches to resolve this issue are to improve the environment in
which the cells are being injected, or to improve the state of the photoreceptors themselves.
Photoreceptor maturation is an important factor in their overall integration efficiency. At the time
of transplantation, the host cells are fully mature cells. Current protocols result in the creation of
various cell types found in the retina, as well as progenitor cells which are not present in the fully
mature retina. Creating mature rods and cones that resemble the stage of the host retina may help
increase photoreceptor integration. This research focuses on the differentiation process and
photoreceptor maturation to increase the integration of stem cell derived photoreceptors into the
retina during transplant. This can help to increase the light response in blind mice, as measured
brain waves responding to light and can have several important therapeutic implications for the
treatment of retinal diseases.
5

Formation of Optic Cups
In order to quickly influence the maturation of the neural stem cells into photoreceptors,
these neural progenitor cells can be cultured in floating low-attachment conditions. In a three
dimensional structure, the neural retina can self-organize into optic cup structures (Nakano et al.,
2012). These hES derived cells organized into a layered structure, with the light sensitive rod and
cone cells lining the outer ring of the spherical cell clusters. Neural spheres, such as these, mimic
the natural organization and structure of the developing eye in vivo. A key feature of these
floating optic cups is the short time they take to form. Within days, the neural progenitor cells
begin to self-organize. Therefore, a three-dimensional cell culture can enhance differentiation
and maturation of these cells, allowing a more efficient method of preparing these cells for
transplantation.
Diabetic Retinopathy
Damage to the retina due to complications of diabetes is a rising concern. Diabetic
Retinopathy (DR) is the leading cause of blindness in people ages 20-64, and accounts for
roughly 12% of new cases of blindness per year (Engelgau et al., 2004). Furthermore, 25% of
diabetic patients reported visual impairments, which is twice the proportion compared to
individuals without diabetes (Saaddine et al., 1999). DR is characterized by an increase of the
permeability in the capillaries and other small vessels in the eye (Singh et al., 2009). While
AMD is the leading cause of blindness among the elderly, DR is predicted to be the leading
cause of blindness among the younger, population (Aiello, 2003; Moss et al., 1998).
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Patients of both type 1 and type 2 diabetes are susceptible to DR. Considering cases with
disease duration over twenty years, 95% of patients with type 1 diabetes have DR, while 60% of
type 2 diabetic patients have DR (Sayin et al., 2015). Hyperglycemia plays an important role in
DR by causing vascular endothelial dysfunction (Matthews et al., 2004), although the precise
mechanism of action is largely unknown. One proposed factor for the negative effects of DR is
chronic oxidative stress (Baynes, 1991; Cui et al., 2006; Kowluru et al., 2001; Zong et al., 2011).
Methylglyoxal (MG) has been tested as a source of oxidative stress (Shipanova et al., 1997) and
leads to the accumulation of advanced glycation end products (AGEs), which are implicated with
retinal complications (Kyselova et al., 2004). Accumulation of AGEs leads to apoptosis in retinal
cells (Denis et al., 2002). MG has been shown to cause accumulation of AGEs and increases
apoptosis of many cell types found in the eye both in vitro and in vivo (Kim et al., 2012).
Specific Aims
Aim 1: To generate mature photoreceptor cells from human-derived pluripotent stem cell lines
Current protocols use the recombinant proteins DKK1, Noggin and IGF1 in order to
differentiate pluripotent cells into retinal cells. Under these protocols, recombinant proteins are
added to the growth medium for two weeks in order to promote retinal stem cell markers such as
CHX10, LHX2 and PAX6. It can take several months for this subset of cells to express mature
photoreceptor markers such as Blue Cone opsin. In contrast, small molecules offer the advantage
of being relatively cheap, more stable, and their ability to easily cross the cell membrane make
them fast-acting. Replacing recombinant proteins with specific small molecules can enhance the
differentiation of stem cells into photoreceptors. Creating, expanding and maturing these stem
cell-derived photoreceptors can greatly improve the number of integrated cells after
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transplantation into Crx -/- mice and theoretically lead to an increased response to light. Here, we
assess the ability of small molecule analogs such as IWR1, SB43152 (SB), and LDN193189
(LDN), to increase the rate of differentiation of retinal stem cells and in turn affect maturation of
the rod and cone photoreceptors (Table 1). Photoreceptors derived from undifferentiated cells
from a healthy patient as well as a family member with RP are used in order to determine any
differences in the maturation process. Theoretically, genetic differences between these family
members may be linked to the disease itself. Since these are degenerative diseases, having
photoreceptors derived from these individuals can allow us to compare the formation and
maturation of these photoreceptors over a long period of time.

Aim 2: Model retinal degenerations such as those associated with Diabetic Retinopathy
using photoreceptors derived from human induced pluripotent stem cells
Access to human cells through stem cell technologies allows us unprecedented ability to
directly study human development and degenerations. Here, we study the effects of diabetes on
the human retina. Using Methylglyoxal (MG), a chief metabolite that accumulates in tissues in
diabetes, we explore the disease development, in vitro, in human stem-cell derived retinal
cultures.

Materials and Methods
Creation of Induced Pluripotent Cells from Human Lymphocytes
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Lymphocytes from both healthy and diseased patients were obtained (Coriell
Biorepository, Camden, NJ) and an iPS cell line was made as previously described (Okita et al.,
2011). iPS cells were made from a patient with RP, as well as an unaffected cousin to serve as the
control. Briefly, fibroblast cultures were electroporated with episomal plasmid vectors. Following
48 hours of electroporation, the media was changed to hES media, consisting of DME/F-12 1:1
(HyClone Logan, UT) with 20% Knockout Serum Replacement (KSR; Gibco, Grand Island, NY),
1% Penicillin Streptomycin Amphotericin B (Lonza, Basel, Switzerland), 1% MEM Nonessential
Amino Acids (Corning, Corning, NY) 100 uM Beta-mercaptoethanol (Sigma Aldrich, St. Louis,
MO) and 5 ng/mL basic FGF (Stemgent, Cambridge, MA). Once the cells began to take on an
undifferentiated morphology, they were manually picked and grown in Essential 8 media (Gibco).
Stem Cell Culture
Human Induced Pluripotent stem cells as well as human embryonic stem cells were
maintained in Essential 8 basal medium (Gibco) supplemented with 1% Essential 8 supplement
(Gibco) and 1% Penicillin Streptomycin Amphotericin B (Lonza). Cells were grown on culture
vessels coated with Matrigel (BD Biosciences, San Jose, CA). The undifferentiated cells were
grown in a 37°C incubator with 5% CO₂ and 5% O₂. Daily media changes were made for the
growth of these cells. The stem cells required passaging when they reached approximately 70%
confluence, generally after 4-5 days of growth. Cells were passaged by an initial wash with 1x
PBS (Corning), followed by the addition of a 1 mM solution of sodium citrate (Sigma Aldrich).
Sodium citrate was aspirated off after 5 minutes and cells were removed by manually scraping
the cells with a 200 uL disposable pipette tip (BioExpress, Kaysville, UT) in the presence of
Essential 8 medium. The cell suspension from a single well was collected and directly passaged
onto all 6 wells of a 6 well plate for a 1:6 passaging ratio.
9

Stem Cell Differentiation into Retinal Stem Cells
The iPS cells were differentiated into Neural Stem Cells (NSC) by adding differentiation
media consisting of DME/F-12 1:1 (HyClone) with 10% Knockout Serum Replacement (KSR;
Gibco), 1% Penicillin Streptomycin Amphotericin B (Lonza), 1% Sodium pyruvate (Corning),
1% Sodium Bicarbonate (Corning), 1% HEPES Buffer (Corning), and 1% MEM Nonessential
Amino Acids (Corning) (Anchan et al., 1991). Following filtration in a 500 mL vacuum-driven
filter system (Argos), 5 mL of N1 Media Supplement (Sigma Aldrich) was added (Price et al.,
2002). Finally, we added the small molecules IWR1 (Sigma Aldrich), SB431542 (Stemgent),
LDN193189 (Stemgent) and the recombinant protein IGF1 (R&D Systems). Cells were allowed
to grow in this medium with daily changes for 5 days. On the fifth day, cells were passaged by
washing the cells once with PBS (Corning), adding 1 mL of Accutase (Global Cell Solutions,
Charlottesville, VA) and letting the Accutase sit for 5 minutes. Then,, the Accutase was
aspirated, and the cells were washed twice with PBS. Next, 2 mL of PBS was added and cells
were manually scraped off the plate using a 200 uL disposable pipette tip (BioExpress). The cell
suspension was centrifuged for three minutes at 1500 rpm at room temperature. The supernatant
was aspirated off and the cell pellet was resuspended in NSC media, and re-plated onto 2 wells
of a 6 well plate, for a passaging ratio of 1:2. NSC media is comprised of DME/F-12 1:1
(HyClone), 0.5% Fetal Bovine Serum (FBS, Atlanta Biologicals), 1% Penicillin Streptomycin
Amphotericin B (Lonza), 1% Sodium pyruvate (Corning), 1% Sodium Bicarbonate (Corning),
1% HEPES Buffer (Corning), and 1% MEM Nonessential Amino Acids (Corning). Following
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filtration in a 500 mL vacuum-driven filter system (Argos), 5 mL of N1 Media Supplement
(Sigma Aldrich) was added. Cells were cultured in this media indefinitely.
Table 1: Recombinant Protein Replacement Strategy

Three Dimensional Neural Cultures
In order to grow the neural progenitor cells as a floating, three dimensional culture,
clusters were removed from the Matrigel coated plate by manually removing the areas of interest
with a 200 uL pipette tip (BioExpress). Selected clusters were moved into an Ultra-Low
Attachment Plate (Corning), and were allowed to grow floating in 2 mL of NSC media. Media
was added twice a week until a volume of 5 mL was reached in the floating well, at which point
the media containing the cells was collected and the cell cultures were allowed to aggregate at
the bottom of a 15 mL centrifuge tube. Spent media was aspirated, and cells were replenished
with 2 mL fresh media and returned to the low attachment plate.
Retinal Pigment Epithelium
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Retinal Pigment Epithelium (RPE) cells were cultured similarly to the neural cells. The
differentiation steps and initial passaging were carried out identically. After passaging, any cells
displaying the morphology typical of RPE cells, including hexagonal shape and any
pigmentation, are manually separated from the neural cells (Figure 3). Using a 200 uL pipette tip,
any region showing RPE morphology was removed, and centrifuged as described above. The
supernatant is aspirated, and the cells are resuspended in RPE media. A 6 well plate of
differentiated cells can be combined to fill one well of a six well plate of newly picked RPE
cells. A 500 mL bottle of RPE media consists of DME/F-12 1:1 (HyClone), 5% Fetal Bovine
Serum (FBS; Atlanta Biologicals), 1% Penicillin Streptomycin Amphotericin B (Lonza), 1%
Sodium pyruvate (Corning), 1% GLUTAMAX (Gibco), 125 mg Taurine (Sigma Aldrich), 10 ug
Hydrocortisone (Sigma Aldrich) and .0065 ug Triiodo-thyronin (Sigma Aldrich). Once the cells
became confluent, the FBS was reduced to 1%. After filtration in a 50 mL vacuum-driven filter
system (Argos, Logan, UT), 5 mL of N1 Media Supplement (Sigma Aldrich) was added.

RNA Extraction, Reverse Transcription and PCR Analysis
RNA was extracted from cells using the Direct-zol RNA MiniPrep kit (Zymo Research,
Irvine, CA). All steps were done according to the manufacturer’s recommended instructions.
RNA samples were quantified and tested for purity using a NanoDrop 2000 machine (Thermo
Scientific). cDNA was synthesized from 500 ng of total RNA template using the iScript cDNA
synthesis kit (Bio-Rad). Reactions occurred in a T100 Thermal Cycler (Bio-Rad, Hercules, CA)
according to the manufacturer’s recommended instructions. Quantitative Real Time PCR
analysis was performed using CFX Connect Real-Time PCR Detection System (Bio-Rad) and
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CFX Manager Software (Bio-Rad). Each sample was done in duplicate. Forward and Reverse
primers (Table 2) were used at a final concentration of 400 nM with 1 uL cDNA sample, 7.4 uL
of DEPC water (GeneMate) and 10 uL of iTaq Universal SYBR Green Supermix (Bio-Rad).
Samples were normalized using the Beta-Actin gene.
Table 2: RT-PCR Primers
Primer
Name

Forward Sequence

Reverse Sequence

β-Actin

GGA TCA GCA AGC AGG AGT AT

GGT GTA ACG CAA CTA AGT CAT AG

Blimp

CCA CAA GAA CTA CAT CCA T

CAT TGA TTC GGG TCA GAT

CGC TCT CAC TTA CCC TTA CAC
Brn3b

ACA

CGG TCA TGC TTC CAA CTG CTT CTT

Chx10

CGA CAC AGG ACA ATC TTT ACC

CAT AGA CGT CTG GGT AGT GG

Crx

GTA CCC AGA CGT CTA TGC C

TTC TTG AAC CAA ACC TGA ACC

Lhx2

TAT CAC CTC AAC TGC TTC ACG

TAG ACC AGG CTG TCC TTC AT

AGT GAA TCA GCT CGG TGG TGT

TGC AGA ATT CGG GAA ATG TCG

Pax6

CTT

CAC

Rx

GTA CCC AGA CGT CTA TGC C

TTC TTG AAC CAA ACC TGA ACC

Ascl1

AGC ACT CTC TCA CTT CTG

CCT TCC TTT CTG ATT TCC TT

Recoverin

CCA CTC TTC CTC ACT CAT

CTC CGA GAA CTT GGT GTT

Immunocytochemistry
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Cells were fixed with 2% Paraformaldehyde (Alfa Aesar, Sparks, NV) for 20 minutes at
room temperature and in the dark. Paraformaldehyde was aspirated off and cells were washed
three times at five minutes each with PBS (Corning) with 0.5% TWEEN (Acros Organics).
Following the washes, samples were blocked with PBS with 0.5% TWEEN and 10% Normal
Donkey Serum (EMD Millipore Darmstadt, Germany). Cells were blocked for one hour prior to
the addition of primary antibody. The primary antibodies were diluted in the block solution.
Cells were incubated in the primary antibody overnight at 4°C in the dark. The primary antibody
(Table 3)was aspirated off and cells underwent three washes as described above. Secondary
antibody (Santa Cruz Biotech, Santa Cruz, CA) was added at a 1:500 dilution in the block
solution. Secondary antibodies covered the cells for one hour at 4°C in the dark. The secondary
solution was aspirated and cells were washed three times as described above. Finally, DAPI
(Enzo Life Sciences Farmingdale, NY) was added to the cells for 30 seconds before removal and
additional washes. Samples were mounted on glass slides (VWR, Radnor, PA) using
Fluoromount-G (Electron Microscopy Science, Hartfield PA).
Table 3: List of Primary Antibodies
Antibody

Company

Dilution

Mouse anti-Pax6

DHSB

1:250

Goat anti-Otx2

BD Biosystems

1:500

Rabbit anti-NRL

Gift from Dr. A.
Swaroop

1:500

Mouse anti-ZO1

DHSB

1:100

Mouse anti-MITF

NeoMarkers

1:50

Goat anti-Sox2

Santa Cruz
Biotechnology

1:100
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Rabbit anti-AIPL1

Gift from Ramamurthy
lab, WVU

1:1000

Rabbit antiRecoverin

EMD Millipore

1:1000

Mouse anti-RETP1

Santa Cruz
Biotechnology

1:200

Phosphohistone-3

Santa Cruz
Biotechnology

1:200

Addition of Methylglyoxal to Neural Cells
Upon maturation of neural retinal cells, around four months, the cells were treated with
one of two conditions. The first condition is a control group, in which media is changed with the
traditional NSC media daily. In the second group, the cells were treated with 1.2 mM
Methylglyoxal (MG) added to the NSC media. This dose was identified following dose-response
cytotoxicity analysis (data not included). Cells were allowed to grow for 24 hours after MG
addition. After 24 hours, cells were collected for PCR analysis and immunocytochemistry.
Results
Formation of iPS cells from Lymphocyte Cultures
Following electroporation, a small subset of lymphocytes began to show morphology
similar to that of an undifferentiated human stem cell approximately 2 weeks following start of
reprogramming (Figure 2, A). Each undifferentiated looking colony was manually isolated and
grown as an independent clone. The best clones were selected and directly compared to H1
undifferentiated (Figure 2B) human stem cells. There was no difference in cell morphology
15

between the H1 stem cell colonies and the undifferentiated colonies of the iPS cells resulting
from lymphocyte reprogramming (Figure 2C).

Figure 2: Progression of Lymphocyte culture (A) three weeks after reprogramming is shown.
Cell morphology is comparable to both H1 undifferentiated embryonic stem cell line (B) and a
previously established induced pluripotent cell line (C).
Differentiation of retinal stem cells and Photoreceptors from iPS Cells
Following five days of differentiation with IWR1, SB, LDN and IGF1 (ISLI), cells were
allowed to grow with daily media changes. RT-PCR was used to analyze the differentiation
progression two weeks after the beginning of differentiation. We see an increase in genes
associated with neural stem cells, as well as genes associated with cell types found in the retina.
There is an increase in gene expression for genes associated with neural stem cells, such as Pax6,
Lhx2 and Rx. Additionally, there is an upregulation of genes coding for differentiated retinal
cells including photoreceptor genes such as Crx, Blimp1 and recoverin and ganglion cells such
as Brn3.
16

Figure 3: Following Differentiation, neural cells and RPE cells are manually isolated and
allowed to grow in homogenous cultures.
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4A) Control iPS Differentiation
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Figure 4: Neural cells derived from iPS cells from control (A) and disease (B) patients qRT-PCR
results. Results normalized to Beta-Actin. All samples compared to undifferentiated cells. All
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genes expressed as undifferentiated stem cells differentiate into neural progenitor cells. Results
indicate 2ⁿ fold expression.

Several different cell types normally found in the human eye are present at 2 weeks post
differentiation (Figure 5). We find the RPE cells, as identified by pigmentation and their
cobblestone-like morphology. Also present are the dark neural clusters, which are eventually
manually picked and grown in floating cultures. Finally, there is evidence of translucent lens
cells in the plate. Each of these cell types underwent purification via manual separation in order
to create a homogenous plate, which was used for further analysis.

Figure 5: Heterogeneous differentiation of iPS cells into various cell types found in the eye.
These heterogeneous cells are manually isolated and allowed to grow further in homogenous
cultures. RPE= Retinal Pigment Epithelium, N=Neural, L=Lens
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Once a homogenous culture was established, immunohistochemistry was performed to
determine the differentiated state of the cells. The cells were stained for Pax6 and Otx2 (Figure
7) at both one and two weeks post differentiation. Cells that are positive for Pax6 are the neural
stem cells, while cells that are Pax6 negative and Otx2 positive are developing photoreceptor
cells. Co-staining of both Pax6 and Otx2 indicates that the cell is either immature and yet to
undergo photoreceptor differentiation, or may still take up an RPE fate. The pattern of circular
staining in the 1 week Pax6 cells is typical of neural rosettes, in which the differentiating cells
move to the center of the rosette to complete differentiation.
In order to compare the differentiation results using the new ISLI protocol with the
established method of using recombinant proteins, we analyzed the cells under identical
differentiation conditions. One subset of iPS cells were differentiated using ISLI, while another
was differentiated using DKK1, IGF1, and Noggin (DIN). RNA was collected after two weeks of
differentiation and genes associated with retinal differentiation were analyzed by RT-PCR
(Figure 6).
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Figure 6: qRT-PCR results comparing cells differentiated with either recombinant proteins or
small molecules. Results indicate a greater expression of relevant neural markers when small
molecules were used for differentiatio as opposed to recombinant proteins.

We see a major increase in the expression of the EFTFs, as well as a marked decrease in
OCT4, which is a marker of pluripotency (Figure 6). Notable, LHX2 goes from a 14 fold
increase to a 50 fold increase, compared to the undifferentiated cells. PAX6 goes from a 229 fold
increase to a 1077 fold increase. Additionally, RX goes increases from a 51 fold increase to a
519 fold increase when using ISLI compared to DIN. These drastic changes indicate the small
molecules are more efficient at differentiating the stem cells into retinal progenitor cells.
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Figure 7: Cells at both one and two weeks after start of differentiation using small molecules.
Expression of Pax6, a neural stem cell marker, and Otx2, a marker of RPE and early
photoreceptors increase as the cells continue to differentiate. Dapi (blue), Pax6 (green) and Otx2
(red).

RPE upon purification can be cultured at high density to allow further maturation. These
cells then express various immature and mature markers of RPE including MITF, Otx2, ZO-1,
CRALBP, PMEL17, BEST1 and RPE65 (Figure. 8). Upon Tissue electron microscopy analysis
(TEM), the cells have typical morphology with apical microvilli, pigmented granules and
abundant mitochondria. (Figure 8 D,E)
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Figure 8: RPE cells display typical morphology, and ZO-1 (B,C,F) and qRT-PCR showed the
expression of additional markers including TYR, BEST1, CRALBP, RPE65 and PMEL17 (G).
The cells were also analyzed by TEM and the maturation features including apical microvilli,
basal nuclei and apical mitochondria and melanosomes (D,E). (Figure courtesy of Dr. Deepak
Lamba)
Establishment of Floating Cultures
The neural regions of the differentiated cells were manually separated from the
heterogeneous culture. Neural cell colonies took up a near spherical shape within hours after
being grown in the ultra-low attachment plates. Circular growths appeared on these clusters,
indicating the development of self-organized optic cups (Figure 9A). At 4 weeks after suspension
culture, these clusters were sectioned and analyzed via immunocytochemistry. Cells along the
outer rim of the cluster were positive for photoreceptor markers Aipl1, Recoverin, NRL and RetP1 (Figure 9B). Additionally, Sox2, a neural stem cell marker, was only evident in the inner
sections of the cluster, indicating a self-organized, layered structure.

23

Figure 9: Floating neural colonies (A) with growth on upper right. Layered organization of cells
indicate self-organization of photoreceptors. Immunocytochemistry confirms cells on outer rim
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of floating cells are positive for photoreceptor genes. AIPL1 (D), Recoverin (E), Ret-P1 (G) are
late photoreceptor markers. Nrl (F), Otx2 (B) are photoreceptor precursor markers. SOX2 is a
marker of neural stem cells.

Diabetic Retinopathy
The inherent inability to accurately model age related diseases such as AMD and RP
causes many problems when it comes to analyzing the evolution of the diseases. Any human
photoreceptors developed from stem cells in vitro would take a similar amount of time to
degenerate as they would in vivo. This would require decades of cell maintenance in order to
observe the effects of the diseases, which is simply impractical. Therefore, it is important to
develop methods to mimic the cellular environment that causes degenerations. Oxidative stress is
believed to have a component in the retinal diseases, so we investigated another retinal
degenerative disease, RP, in which oxidative stress has more of a well-defined role.
As stated above, one of the major metabolites to accumulate in tissues during diabetes is
MG. Here, we wanted to look at the role of MG on retinal stem cells and retinal neuronal
morphology as well as its potential effects on driving the intracellular oxidative stress. Several
changes resulted in the addition of MG to neural cells growing in vitro on Matrigel plates. MG
addition results in the cells exhibiting characteristics of stress including complete loss of
proliferation as evidenced by a lack of Phosphohistone-H3 (PH3), a key marker of cell division
(Figure 10A). Additionally, we observed alterations in the TUJ expression pattern, such as
shortened or fragmented processes. In the control cells, the TUJ is present along the full length of
the healthy axons. However, in the cells treated with MG, the axons appear fragmented, and their
numbers are decreased. Taken together, these changes indicate that the neural cells are reducing
proliferation and retracting axons, as a result of the stress caused by MG. Additionally, there is a
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marked increase in TUNEL staining with the addition of MG (Figure 10B). TUNEL staining
works by fluorescently labeling the ends of fragmented DNA segments, and is a marker of cell
apoptosis. The control group has very low levels of TUNEL positive cells, as expected with a
developing neural cell colony. Conversely, the addition of MG causes a drastic increase in the
number of TUNEL positive cells, indicating an increase in apoptosis. Finally we assess if any of
these changes are due to oxidative stress by looking at both NRF2 expression as well as its
downstream effects, NQO1, HMOX1 and GSH components. We observed that HMOX1 was
significantly upregulated within 24 hours of MG stress (Figure 10C). Each gene tested through
qRT-PCR is a known effector involved in detoxification. By seeing an increase in the expression
of HMOX1, there is a strong indication that this pathway specifically is being upregulated. The
different effectors respond to different stressors, and our data indicates that in the presence of
oxidative stress induced by MG, the iron based enzyme HMOX1 was upregulated in order to
detoxify the environment.
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Figure 10: (A) Control neural cells and cells treated with methylglyoxal are visualized with
DAPI staining (blue). Treatment of methylglyoxal results in the loss of p-histone H3 positive
cells (green). Neural axons become retracted, and there is evidence of axon fragmentation
following methylglyoxal treatment, as visualized by TUJ staining (red). (B): Treatment of
neurons with methylglyoxal results in a major increase in TUNEL staining (red). Cells are
visualized with DAPI (blue). (C): qRT-PCR data showing relative gene expression as compared
to control.

Discussion
Differentiation and purification of induced pluripotent stem cells into cell types present in
the neural retina is an important step towards developing mature photoreceptors for
transplantation. This novel method of differentiation effectively allows development of mature
photoreceptors. RT-PCR analysis indicates these cells have gene expression changes similar to
the photoreceptors generated using recombinant proteins, but at a faster pace. We see, in 5 days,
a similar level of differentiation with the small molecules that is found after 2 weeks of using
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recombinant proteins. This is likely due to the stability of the small molecules in culture
conditions, as well as their ability to easily cross the cell membrane. Additionally, further
maturation is possible by creating floating cultures of these neural cells. In order for cell therapy
to be a viable option for cell replacement by transplantation, a large source of replenishing cells
must be available. Using small molecules, as opposed to recombinant proteins, reduces the cost
of creating these photoreceptors and decreases the time it takes to grow these cells from nine
weeks to four weeks.
The floating cultures and pattern of mature photoreceptors mirror the development of the
eye in vivo. While the cells we develop in a dish form photoreceptors, they do not reach full
maturity due to the lack of a proper cellular milieu. The self-formation of the optic cups aids in
the construction of cell layers that mimic the natural development of photoreceptors in vivo.
These optic cups artificially mimic the environment of the retina in an embryonic stage as it
undergoes development. This process enhances the differentiation process by allowing the cells
to grow as a three dimensional cluster. Establishment of this protocol has provided a source of
healthy and mature photoreceptors that are prepared for transplantation. This process more
efficiently generates rod and cone photoreceptors in vitro than the previously described methods.
The natural ability of the cells to self-organize and form the three-dimensional structures found
in the eye is an intriguing discovery. Neural clusters formed from the differentiation of iPS cells
have the capability of forming the organized and regulated structure of the retina. Photoreceptors
line the outside ring of these clusters, while Sox2 positive ganglion cells form the interior of
these neural spheres. Although the mechanism of how the cells migrate into the correct position
and orientation is unknown, the finding that they can self-orient in vitro is an encouraging sign
for the possibility that they can correctly orient in vivo after transplantation. Injection of
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photoreceptors into the sub-retinal space of a mouse eye should prove sufficient to allow the
cells to properly integrate into the host retina. Applications for this novel process can be
extended to the other cell types present including RPE cells. The relationship between RPE cells
and photoreceptors plays an important role in maintaining a healthy environment to prevent
degeneration of the photoreceptors. Further elucidating this relationship is now possible because
of our new methods of quickly generating these cell types as described above.
A key advantage to using the iPS cell lines is the ability to compare the photoreceptors
derived from a healthy individual with cells from an individual with a retinal disease. Both of the
retinal diseases associated with aging and diabetic retinopathy initially require healthy
photoreceptor cells, and the degeneration of these cells results from disease progression.
However, it is possible to utilize the photoreceptors we have created in the lab to examine the
differences in gene expression between the healthy and diseased cells. Additionally, creating
photoreceptors in vitro from the lymphocytes of an individual with a retinal disease allows the
cells to be monitored closely over time, in an effort to elucidate the process of their degeneration.
Once the lymphocytes are reprogrammed into a pluripotent state, they essentially revert to an
embryonic state. Photoreceptors that differentiate through the above protocols are young, and are
not yet degenerating. We can follow these cells and monitor gene expression levels, among other
indications of cell stress, to determine the age and mechanism of degeneration. Artificial
stressors can be added to mimic the environment in the eye. While these diseases often take
decades to progress in vivo, this process can be greatly accelerated in vitro.
The findings that treatment of neural cells with Methylglyoxal caused a decrease in cell
division and increases apoptosis is expected, yet it offers a possible new approach to study
diabetic retinopathy. While the mechanism of disease progression is not yet well understood,
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accumulation of oxidative stress and advanced glycation end products (AGEs) that results in
photoreceptor death is a plausible route. Through findings such as decrease in pH3 levels,
revealing a decrease in proliferation, decreased and fragmented TUJ expression and an increase
in apoptosis; it is clear that the addition of MG is having a negative effect on the photoreceptors.
However, it is unknown whether this mirrors the progression of DR in vivo. Additionally, further
testing is required to observe the long-term impact of a low dose of MG, mirroring chronic
oxidative stress.
Taken together, the DR data can be approached in a similar fashion to retinal diseases
such as AMD and RP. The replacement of photoreceptors damaged as a result of the progression
of these diseases is going to be a critical component of restoring vision. Additionally, creating
these photoreceptors through iPS cell lines holds several distinct advantages, including the
opportunity to use the iPS lines to study disease progression. More research is required to
pinpoint the specific degenerations caused by these diseases in an effort to prevent photoreceptor
deterioration. However, we have made a significant step by generating a method that allows for
the generation of a large number of photoreceptors. The protocol outlined here provides a
cheaper, and faster method of differentiating these mature photoreceptors from ES and iPS
human cell lines.
Minimizing the amount of time and money required to develop a source of mature
photoreceptor cells has many benefits. In addition to a renewable source of cells for
transplantation, creating three dimensional structures can be a valuable tool for further research.
These models can help to discover the progression of the disease, as well as provide a more
reliable method for drug screening. The ability to more closely model the eye in vivo can help
find targeted drugs to combat these age-related degenerative diseases.
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